Versant Venture Management’s Cymabay Therapeutics CBAY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-543,753	Closed	-$5.95M	–	9
2023 Q2	$5.95M	Hold	543,753	–	–	7.06%	5
2023 Q1	$4.74M	Hold	543,753	–	–	9.88%	4
2022 Q4	$3.41M	Hold	543,753	–	–	7.05%	4
2022 Q3	$1.9M	Hold	543,753	–	–	3.24%	6
2022 Q2	$1.6M	Hold	543,753	–	–	2.46%	7
2022 Q1	$1.69M	Hold	543,753	–	–	1.69%	9
2021 Q4	$1.84M	Hold	543,753	–	–	0.98%	9
2021 Q3	$1.99M	Hold	543,753	–	–	0.82%	10
2021 Q2	$2.37M	Hold	543,753	–	–	0.79%	10
2021 Q1	$2.47M	Hold	543,753	–	–	0.48%	10
2020 Q4	$3.12M	Hold	543,753	–	–	0.32%	11
2020 Q3	$3.94M	Hold	543,753	–	–	0.72%	9
2020 Q2	$1.9M	Hold	543,753	–	–	0.27%	10
2020 Q1	$805K	Hold	543,753	–	–	0.22%	7
2019 Q4	$1.07M	Hold	543,753	–	–	0.32%	6
2019 Q3	$2.78M	Hold	543,753	–	–	1.08%	7
2019 Q2	$3.89M	Sell	543,753 -540,943	-50%	-$3.87M	1.13%	6
2019 Q1	$14.4M	Hold	1,084,696	–	–	4.76%	4
2018 Q4	$8.54M	Hold	1,084,696	–	–	4.23%	5
2018 Q3	$12M	Buy	1,084,696 +36,095	+3%	+$400K	4.09%	5
2018 Q2	$14.1M	Hold	1,048,601	–	–	4.39%	4
2018 Q1	$13.6M	Hold	1,048,601	–	–	4.36%	5
2017 Q4	$9.65M	Hold	1,048,601	–	–	10.15%	4
2017 Q3	$8.26M	Hold	1,048,601	–	–	6.29%	6
2017 Q2	$6.04M	Hold	1,048,601	–	–	4.75%	6
2017 Q1	$4.51M	Hold	1,048,601	–	–	3.28%	7
2016 Q4	$1.81M	Hold	1,048,601	–	–	1.77%	7
2016 Q3	$2.03M	Hold	1,048,601	–	–	2.27%	7
2016 Q2	$1.82M	Hold	1,048,601	–	–	1.85%	5
2016 Q1	$1.42M	Hold	1,048,601	–	–	1.02%	7
2015 Q4	$1.77M	Hold	1,048,601	–	–	1.04%	7
2015 Q3	$2.03M	Hold	1,048,601	–	–	1.17%	7
2015 Q2	$2.82M	Hold	1,048,601	–	–	3.58%	5
2015 Q1	$7.26M	Hold	1,048,601	–	–	6.38%	4
2014 Q4	$10.3M	Buy	+1,048,601	New	+$10.3M	9.86%	4